EN DE
STOCK COMPARISON

Limes Schlosskliniken vs HCA Healthcare: Fair Value & Quality

Both stocks run through our valuation models. Here is how Limes Schlosskliniken (LIK) and HCA Healthcare (HCA) compare, as of Aug 11, 2026.

As of Aug 11, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Limes Schlosskliniken trades at €585 versus a fair value of €421 (-28%), while HCA Healthcare trades at $413 versus $555 (+34%).
Limes Schlosskliniken
LIK.XETRA · EUR · Health Care
-28%
upside to fair value
overvalued
Price€585
Fair Value€421
Quality62/100
HCA Healthcare
HCA · USD · Health Care
+34%
upside to fair value
undervalued
Price$413
Fair Value$555
Quality70/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Limes SchlossklinikenHCA Healthcare
Valuation
28.5×P/E (TTM)12.5×
3.75×P/S (TTM)1.06×
7.41×P/B
14.7×EV/EBITDA7.8×
PEG1.18×
1.9%Dividend yield0.8%
€10.00Dividend per share$2.94
Profitability
11%Net margin9%
16%Operating margin15%
30%Return on equity136%
14%Return on assets12%
Growth
43%Revenue growth (YoY)4%
20.2%Avg. growth/yr (3Y)7.9%
35.3%Avg. growth/yr (5Y)8.0%
Balance & size
0.42×Debt / equity
$188MMarket cap$81B
expensiveGrowth qualityhealthy

Limes Schlosskliniken leads: 7 to 4 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Limes Schlossklinikenof which business quality 63 · market factors 79 HCA Healthcareof which business quality 66 · market factors 46
ProfitabilityMargins and returns on capital today
73
76
Quality GrowthAre margins and returns improving?
79
61
CashflowEarnings quality: real cash, not paper profit
42
62
Fin. StrengthBalance sheet, leverage, solvency risk
88
39
InvestmentDisciplined investing over empire-building
6
75
Low VolatilityCalm price path (market factor)
55
59
MomentumPrice trend over the last 3–12 months (market factor)
82
38
52W MomentumDistance to the 52-week high (market factor)
100
44
Net IssuanceBuybacks instead of dilution
71
100

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Limes Schlosskliniken

DCF Models€403
Earnings-Based€573
Multiples€413
Asset-Based€56.92
Growth DCF€254
Economic Profit€215
Growth Earnings€716

20 of 24 models see the stock below the current price.

HCA Healthcare

DCF Models$546
Earnings-Based$289
Dividend Discount$53.85
Multiples$673
Growth DCF$540
Economic Profit$419
Growth Earnings$506

6 of 23 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Limes Schlosskliniken
Bear €222Fair Value €421Bull €526
€585 = current price (white tick)
HCA Healthcare
Bear $270Fair Value $555Bull $841
$413 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Limes Schlosskliniken · Health Care

Quality score62 · above median
Fair value upside-28% · above median

HCA Healthcare · Health Care

Quality score70 · Top 25%
Fair value upside+34% · Top 25%

Bottom line

As of Aug 11, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Limes Schlosskliniken trades at €585 versus a fair value of €421 (-28%), while HCA Healthcare trades at $413 versus $555 (+34%).

HCA Healthcare has the higher quality score (70/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.